Table I.
Immunoexpression of MSC markers in patients with or without disease recurrence.
Disease stage | Immunoexpression of MSC markers
|
|||
---|---|---|---|---|
CD133 (%) | ABCB5 (%) | CD166 (%) | Nestin (%) | |
Group I: no recurrence (n=18) | 5/18 (27) | 8/18 (44) | 10/18 (55) | 16/18 (88) |
Group II: recurrence (n=18) | 11/18a(61) | 9/17 (52) | 9/18 (50) | 15/18 (83) |
p<0.02 (Fisher’s exact test); p<0.025 (Odds ratio analysis). Relative risk of CD133 overexpression = 2.2.